Previous studies have shown that imatinib inhibits PDGF-induced Akt phosphorylation in vascular smooth muscle cells [33] and IRS-associated PI 3-kinase activity in leukemia cells [34,35]. This evidence concerns the gene AKT1 and leukemia.